HOME LOGIN DOCUMENT RESOURCES FAQs CONTACT INFO
Center for Biologic Counterterrorism
and Emerging Diseases CBC-ED
MedStar Health Group   Washington, DC     Cloud Updated Monday, May 20, 2013 23:15 EST
Craig Feied, MD, FACEP, FAAEM   Jon Handler, MD, FACEP   Michael Gillam, MD
Switch to framed viewerLogged in as: guest ()  
Ebola

Ebola Haemorrhagic Fever Outbreak In Masindi District, Uganda Outbreak Description And Lessons Learned
BMC Infectious Diseases | Abstract | [12/28/2011]

Protein Essential For Ebola Virus Infection Is A Promising Antiviral Target
[8/26/2011]

Replication, Pathogenicity, Shedding, And Transmission Of Zaire Ebolavirus In Pigs
Journal of Infectious Diseases [5/15/2011]

T Cell Immunoglobulin And Mucin Domain 1 (TIM 1) Is A Receptor For Zaire Ebolavirus And Lake Victoria Marburgvirus
Proceedings of the National Academy of Science [5/4/2011]

Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
May 20 2010: PloS Pathogens [5/21/2010]

Scientists Render Ebola Harmless
February 11 2010: Scientist Live article [2/10/2010]

Single Host Gene May Hold Key To Treating Both Ebola And Anthrax Infections
[8/21/2009]

Ebola and hemorrhagic fever
eMedicine article by David Piggot [2/11/2009]

CDC - Ebola Fact Sheet
[2/11/2009]

NICD Arenavirus Outbreak 10 2008 (pdf)
[12/8/2008]

2008 11 29 Bundibugyu Ebola
[11/30/2008]

PLoS Pathogens Newly Discovered Ebola Virus Associated With Hemorrhagic Fever Outbreak In Uganda
[11/20/2008]

Scientists Uncover Ebola Cell Invasion Strategy
[9/2/2008]

Investigating cause of death during an outbreak of Ebola virus haemorrhagic fever: draft verbal autopsy instrument
WHO Epidemic and Pandemic Alert and Response [1/5/2008]

Ebola Virus
Emedicine article [1/5/2008]

Fruit bats may be Ebola reservoir
The Scientist December 1, 2005 [12/9/2005]

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys
Lancet: December 13, 2003 [1/14/2004]

National Institutes of Health: Fast-Acting Ebola Vaccine Protects Monkeys
Fast-Acting Ebola Vaccine Protects Monkeys August 2003: A single shot of a fast-acting, experimental Ebola vaccine successfully protects monkeys from the deadly virus after only one month. [11/4/2003]
Ebola Bepast Newsletters

New Subtype of Ebola Virus (#5) reported from 2007 Uganda Outbreak: Estimated 36% Fatality Rate
[11/28/2008]

[This site developed and operated by Craig Feied MD, Jon Handler MD, and Mike Gillam MD]